Efficacy and Safety of Sacituzumab Govitecan on Advanced HER2-negative Breast Cancer: A Meta-analysis

Efficacy and Safety of Sacituzumab Govitecan on Advanced HER2-negative Breast Cancer: A Meta-analysis

Objective To explore the efficacy and safety of Sacituzumab govitecan on patients with advanced HER2-negative breast cancer. Methods We classified and analyzed the relevant phase Ⅱ or Ⅲ clinical trials published by May 2021, and used the Stata 12.0 software package for analyzing efficacy and toxicit...

Full description

Bibliographic Details
Main Authors: ZHANG Qian, LI Na, YANG Hua
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-04-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
breast cancer
sacituzumab govitecan
clinical trial
meta analysis
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0757

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.0757

Similar Items